CME Group CEO Terry Duffy has announced his decision to step down from his role, according to market reports. This announcement has led to a 4% decline in CME Group's stock price during pre-market trading, reflecting investor concerns over the leadership change. Duffy's departure marks a significant shift for the company, which is a major player in the global derivatives market.